FindTrial
Sign In

Role of inflammation in repeated pregnancy loss

Role of inflammatory markers (serum ferritin, C-reactive protein, interleukin 6) in recurrent pregnancy loss - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073762
Enrollment
100
Registered
2024-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O039- Complete or unspecified spontaneous abortion without complication

Interventions

Control Intervention1: Nil: Nil

Sponsors

None
Lead Sponsor
Dr Y M Mala
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: FOR CASES: Pregnant women with two consecutive miscarriages. FOR CONTROLS: Pregnant women without history of any miscarriage and with period of gestation and body mass index matched to that of study group

Exclusion criteria

Exclusion criteria: Pregnant woman with- 1.Known uterine anomalies 2.Chronic inflammatory diseases 3.Any acute illness in last 3 months HIV, Hepatitis B, Hepatitis C, VDRL infections 4.Any intramuscular injection in last 3 weeks 5.Steroids or immunomodulator therapy 6.Moderate to severe anemia 7.Diabetes and thyroid dysfunction 8.Diagnosed autoimmune disorders 9.Toxoplasmosis 10.Diagnosed fetal anomalies

Design outcomes

Primary

MeasureTime frame
Association of inflammatory markers with recurrent pregnancy loss Timepoint: 1yr—

Secondary

MeasureTime frame
Difference in the level of inflammatory markers between women with recurrent pregnancy loss & normal pregnant women Timepoint: 1yr—

Countries

India

Contacts

Public ContactShami Aara

Maulana Azad Medical College

ym_mala@yahoo.com01123235824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026